泰格医药

- 300347

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
泰格医药(300347) 利润表
单位:万元
报表日期2024-03-312023-12-312023-09-302023-06-302023-03-31
一、营业总收入166,020.43738,403.95565,047.79371,085.04180,457.14
营业收入166,020.43738,403.95565,047.79371,085.04180,457.14
二、营业总成本130,528.78555,412.47414,218.66272,002.55136,029.14
营业成本103,208.07453,551.06337,092.01222,976.35108,904.89
营业税金及附加770.052,786.672,143.601,480.48684.95
销售费用4,645.2318,731.4813,270.368,899.844,491.11
管理费用17,706.8565,020.1452,754.3134,647.1017,092.36
财务费用-2,192.04-10,832.40-10,575.94-8,809.46-1,596.11
研发费用6,390.6226,155.5119,534.3212,808.256,451.94
资产减值损失----------
公允价值变动收益1,275.3335,277.0671,039.4352,975.7617,641.27
投资收益-359.1233,817.5312,773.549,890.212,578.47
其中:对联营企业和合营企业的投资收益--10,518.30--6,372.44--
汇兑收益----------
三、营业利润36,219.62248,694.06231,172.43159,859.7863,089.78
加:营业外收入30.121,345.40687.11454.9784.80
减:营业外支出13.331,186.15412.59400.2468.37
其中:非流动资产处置损失----------
四、利润总额36,236.42248,853.31231,446.94159,914.5163,106.21
减:所得税费用4,979.3833,860.6228,662.2419,105.516,273.65
五、净利润31,257.04214,992.68202,784.70140,809.0056,832.57
归属于母公司所有者的净利润23,507.20202,485.00187,960.44138,833.7056,845.51
少数股东损益7,749.8412,507.6914,824.251,975.30-12.94
六、每股收益
基本每股收益(元/股)0.27002.34002.17001.61000.6600
稀释每股收益(元/股)0.27002.34002.17001.61000.6600
七、其他综合收益-2,223.925,351.616,697.0710,316.31-4,655.39
八、综合收益总额29,033.12220,344.29209,481.77151,125.3152,177.18
归属于母公司所有者的综合收益总额22,750.21206,283.31192,104.26145,820.7553,759.46
归属于少数股东的综合收益总额6,282.9014,060.9817,377.515,304.56-1,582.28
下载全部历史数据到excel中 返回页顶